{"id":2153,"date":"2019-11-04T13:36:40","date_gmt":"2019-11-04T13:36:40","guid":{"rendered":"https:\/\/vallis.pt\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/"},"modified":"2024-10-10T15:14:28","modified_gmt":"2024-10-10T15:14:28","slug":"vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel","status":"publish","type":"post","link":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/","title":{"rendered":"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group"},"content":{"rendered":"<p>El <strong>Fondo Vallis Sustainable Investments II <\/strong>informa de que ha completado su primera inversi\u00f3n con la adquisici\u00f3n del 50% del capital de <strong>Viable Health Clinical Group, <\/strong>liderando una coinversi\u00f3n con el gestor brit\u00e1nico de <em>capital riesgo<\/em>, <strong>Hermes GPE.<\/strong><\/p>\n<p><strong>Sa\u00fade Vi\u00e1vel <\/strong>es el mayor Grupo Cl\u00ednico dedicado exclusivamente al Diagn\u00f3stico, Tratamiento e Investigaci\u00f3n en Salud y Trasplante Capilar, con instalaciones en Lisboa, Oporto, Vilamoura y Madrid.<\/p>\n<p>En los \u00faltimos cinco a\u00f1os, <strong>Viable Health <\/strong>ha crecido a un ritmo medio anual superior al 50%, alcanzando en 2018 una Facturaci\u00f3n cercana a los 17 millones de euros, a lo que ha contribuido la alta calidad de los m\u00e1s de 30.000 trasplantes capilares realizados y la confianza ganada de sus pacientes.<\/p>\n<p>Fundado en 2009, el Grupo cuenta hoy con m\u00e1s de 200 empleados, entre M\u00e9dicos, Enfermeros, Asesores Cl\u00ednicos e Investigadores, con una Academia para la formaci\u00f3n espec\u00edfica y avanzada de sus profesionales.<\/p>\n<p><strong>Sa\u00fade Vi\u00e1vel <\/strong>cuenta con un Departamento de Investigaci\u00f3n en Rob\u00f3tica y Terapias Celulares en colaboraci\u00f3n con el I3S &#8211; Instituto de Investigaci\u00f3n e Innovaci\u00f3n en Salud de la Universidad de Oporto, a trav\u00e9s del cual se realizan investigaciones sobre C\u00e9lulas Madre procedentes de unidades foliculares con vistas al avance cient\u00edfico en el tratamiento para solucionar la calvicie.<\/p>\n<p><strong>Sa\u00fade <\/strong>Vi\u00e1vel, en asociaci\u00f3n con uno de los mayores iconos del deporte mundial, sin\u00f3nimo de esfuerzo, dedicaci\u00f3n y dinamismo &#8211; <strong>Cristiano Ronaldo <\/strong>&#8211; inici\u00f3 su expansi\u00f3n internacional en marzo de 2019, habiendo abierto su primera cl\u00ednica en Madrid, con la marca <strong>Insparya, <\/strong>que ya ha alcanzado el liderazgo del mercado en n\u00famero de trasplantes capilares realizados en este per\u00edodo. El inter\u00e9s personal de <strong>Cristiano Ronaldo <\/strong>en el \u00e1rea de la salud, as\u00ed como el reconocimiento de la calidad del proyecto cl\u00ednico, estuvieron en el origen de esta asociaci\u00f3n con <strong>Viable Health<\/strong>.<\/p>\n<p>Con esta asociaci\u00f3n entre Vallis Sustainable Investments II Fund, Hermes GPE y su Fundador y CEO, <strong>Paulo Ramos, <\/strong>que mantendr\u00e1 el 50% del capital, el <strong>Grupo Viable Health <\/strong>llevar\u00e1 a cabo una estrategia de expansi\u00f3n internacional basada en la apertura de cl\u00ednicas en las principales ciudades europeas, dise\u00f1ada para alcanzar el liderazgo mundial en el sector, manteniendo un enfoque en el servicio cl\u00ednico de alta calidad a cada paciente.<\/p>\n<h4>Acerca del Grupo Viable Health:<\/h4>\n<p>Sa\u00fade Vi\u00e1vel es el mayor Grupo Cl\u00ednico portugu\u00e9s dedicado exclusivamente al Diagn\u00f3stico, Tratamiento e Investigaci\u00f3n en Salud y Trasplante Capilar, con instalaciones en Lisboa, Oporto, Vilamoura y Madrid.<\/p>\n<p><a href=\"http:\/\/www.saudeviavel.pt\/\">www.saudeviavel.pt<\/a><\/p>\n<p>&nbsp;<\/p>\n<h4>Acerca del Fondo Vallis Sustainable Investments II:<\/h4>\n<p>El Fondo Vallis Sustainable Investments II, FCR, regulado por la CMVM, es el segundo Fondo de Capital Riesgo iniciado por Vallis Capital Partners, con un objetivo de capitalizaci\u00f3n de 150 millones de euros. Este Fondo, lanzado en 2019, sucede a Vallis Sustainable Investments I, que cuenta con una capitalizaci\u00f3n de 75 millones de euros.<\/p>\n<p>El Fondo Vallis Sustainable Investments II opera de acuerdo con criterios Socialmente Responsables, priorizando, en su estrategia de inversi\u00f3n, empresas que formen parte de segmentos de mercado con alto potencial de crecimiento.<\/p>\n<p>Esta transacci\u00f3n se beneficia del apoyo de la Uni\u00f3n Europea bajo el Instrumento de Capital para el Crecimiento establecido por el Reglamento (UE) N\u00ba 1287\/2013 del Parlamento Europeo y del Consejo que establece un Programa para la Competitividad de las Empresas y las Peque\u00f1as y Medianas Empresas (COSME) (2014-2020), as\u00ed como del apoyo del FEG (Fondo Paneuropeo de Garant\u00eda), implementado por el Fondo Europeo de Inversiones con el apoyo financiero de los Estados miembros participantes. Adem\u00e1s, la operaci\u00f3n fue cofinanciada por el Fondo de Capital y Cuasi Capital (FC&amp;QC) y por el Fondo de Fondos para la Internacionalizaci\u00f3n (FFI), ambos gestionados por el Banco Portugu\u00e9s de Fomento, S.A.<\/p>\n<p><img decoding=\"async\" class=\"alignnone wp-image-2716\" src=\"https:\/\/vallis.pt\/wp-content\/uploads\/2024\/10\/logo-ce-horizontal-pt-quadri-lr-300x90.jpg\" alt=\"\" width=\"194\" height=\"58\" srcset=\"https:\/\/vallis.pt\/wp-content\/uploads\/2024\/10\/logo-ce-horizontal-pt-quadri-lr-300x90.jpg 300w, https:\/\/vallis.pt\/wp-content\/uploads\/2024\/10\/logo-ce-horizontal-pt-quadri-lr.jpg 461w\" sizes=\"(max-width: 194px) 100vw, 194px\" \/><img decoding=\"async\" class=\"alignnone wp-image-2574\" src=\"https:\/\/vallis.pt\/wp-content\/uploads\/2024\/01\/eif_logo_rgb_blue_reduced.jpg\" alt=\"\" width=\"111\" height=\"50\" \/><img decoding=\"async\" class=\"alignnone wp-image-2580\" src=\"https:\/\/vallis.pt\/wp-content\/uploads\/2024\/01\/FFC-300x88.png\" alt=\"\" width=\"170\" height=\"50\" srcset=\"https:\/\/vallis.pt\/wp-content\/uploads\/2024\/01\/FFC-300x88.png 300w, https:\/\/vallis.pt\/wp-content\/uploads\/2024\/01\/FFC.png 547w\" sizes=\"(max-width: 170px) 100vw, 170px\" \/> \u00a0<img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-2586\" src=\"https:\/\/vallis.pt\/wp-content\/uploads\/2024\/01\/FFI-300x139.png\" alt=\"\" width=\"117\" height=\"54\" srcset=\"https:\/\/vallis.pt\/wp-content\/uploads\/2024\/01\/FFI-300x139.png 300w, https:\/\/vallis.pt\/wp-content\/uploads\/2024\/01\/FFI.png 538w\" sizes=\"(max-width: 117px) 100vw, 117px\" \/><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-2732\" src=\"https:\/\/vallis.pt\/wp-content\/uploads\/2024\/10\/BPF.png\" alt=\"\" width=\"85\" height=\"52\" \/><\/p>\n<p>&nbsp;<\/p>\n<h4>Acerca de Hermes GPE:<\/h4>\n<p>Hermes GPE es una gestora de <em>capital riesgo <\/em>con sede en el Reino Unido centrada en inversiones en fondos y coinversiones en operaciones de compra de participaciones y captaci\u00f3n de capital de crecimiento, que actualmente gestiona activos por valor de unos 6.000 millones de USD, a trav\u00e9s de una amplia gama de instrumentos financieros de inversi\u00f3n y en asociaci\u00f3n con un amplio abanico de inversores.<\/p>\n<p><a href=\"http:\/\/www.hermesgpe.com\/\">www.hermesgpe.com<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>El Fondo Vallis Sustainable Investments II informa de que ha completado su primera inversi\u00f3n con la adquisici\u00f3n del 50% del capital de Viable Health Clinical Group, liderando una coinversi\u00f3n con el gestor brit\u00e1nico de capital riesgo, Hermes GPE. Sa\u00fade Vi\u00e1vel es el mayor Grupo Cl\u00ednico dedicado exclusivamente al Diagn\u00f3stico, Tratamiento e Investigaci\u00f3n en Salud y [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":1894,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[28],"tags":[],"class_list":["post-2153","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group - Vallis Capital Partners<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group - Vallis Capital Partners\" \/>\n<meta property=\"og:description\" content=\"El Fondo Vallis Sustainable Investments II informa de que ha completado su primera inversi\u00f3n con la adquisici\u00f3n del 50% del capital de Viable Health Clinical Group, liderando una coinversi\u00f3n con el gestor brit\u00e1nico de capital riesgo, Hermes GPE. Sa\u00fade Vi\u00e1vel es el mayor Grupo Cl\u00ednico dedicado exclusivamente al Diagn\u00f3stico, Tratamiento e Investigaci\u00f3n en Salud y [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/\" \/>\n<meta property=\"og:site_name\" content=\"Vallis Capital Partners\" \/>\n<meta property=\"article:published_time\" content=\"2019-11-04T13:36:40+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-10-10T15:14:28+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vallis.pt\/wp-content\/uploads\/2019\/11\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"720\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Gest\u00e3o Vallis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gest\u00e3o Vallis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"5 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/\"},\"author\":{\"name\":\"Gest\u00e3o Vallis\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#\\\/schema\\\/person\\\/f966934c80caeb0ba208e7cadd02a3db\"},\"headline\":\"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group\",\"datePublished\":\"2019-11-04T13:36:40+00:00\",\"dateModified\":\"2024-10-10T15:14:28+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/\"},\"wordCount\":748,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg\",\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/\",\"url\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/\",\"name\":\"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group - Vallis Capital Partners\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg\",\"datePublished\":\"2019-11-04T13:36:40+00:00\",\"dateModified\":\"2024-10-10T15:14:28+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg\",\"contentUrl\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg\",\"width\":1080,\"height\":720},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/es\\\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/vallis.pt\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#website\",\"url\":\"https:\\\/\\\/vallis.pt\\\/\",\"name\":\"VALLIS Capital Partners\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/vallis.pt\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#organization\",\"name\":\"VALLIS Capital Partners\",\"alternateName\":\"Gestora de Fundos Independente, focada exclusivamente em Capital de Risco Private Equity\",\"url\":\"https:\\\/\\\/vallis.pt\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/cropped-favicon-vallis.png\",\"contentUrl\":\"https:\\\/\\\/vallis.pt\\\/wp-content\\\/uploads\\\/2021\\\/12\\\/cropped-favicon-vallis.png\",\"width\":512,\"height\":512,\"caption\":\"VALLIS Capital Partners\"},\"image\":{\"@id\":\"https:\\\/\\\/vallis.pt\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/valliscapitalpartners\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/vallis.pt\\\/#\\\/schema\\\/person\\\/f966934c80caeb0ba208e7cadd02a3db\",\"name\":\"Gest\u00e3o Vallis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g\",\"caption\":\"Gest\u00e3o Vallis\"},\"url\":\"https:\\\/\\\/vallis.pt\\\/es\\\/author\\\/vallis\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group - Vallis Capital Partners","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/","og_locale":"es_ES","og_type":"article","og_title":"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group - Vallis Capital Partners","og_description":"El Fondo Vallis Sustainable Investments II informa de que ha completado su primera inversi\u00f3n con la adquisici\u00f3n del 50% del capital de Viable Health Clinical Group, liderando una coinversi\u00f3n con el gestor brit\u00e1nico de capital riesgo, Hermes GPE. Sa\u00fade Vi\u00e1vel es el mayor Grupo Cl\u00ednico dedicado exclusivamente al Diagn\u00f3stico, Tratamiento e Investigaci\u00f3n en Salud y [&hellip;]","og_url":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/","og_site_name":"Vallis Capital Partners","article_published_time":"2019-11-04T13:36:40+00:00","article_modified_time":"2024-10-10T15:14:28+00:00","og_image":[{"width":1080,"height":720,"url":"https:\/\/vallis.pt\/wp-content\/uploads\/2019\/11\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg","type":"image\/jpeg"}],"author":"Gest\u00e3o Vallis","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Gest\u00e3o Vallis","Tiempo de lectura":"5 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/#article","isPartOf":{"@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/"},"author":{"name":"Gest\u00e3o Vallis","@id":"https:\/\/vallis.pt\/#\/schema\/person\/f966934c80caeb0ba208e7cadd02a3db"},"headline":"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group","datePublished":"2019-11-04T13:36:40+00:00","dateModified":"2024-10-10T15:14:28+00:00","mainEntityOfPage":{"@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/"},"wordCount":748,"commentCount":0,"publisher":{"@id":"https:\/\/vallis.pt\/#organization"},"image":{"@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/#primaryimage"},"thumbnailUrl":"https:\/\/vallis.pt\/wp-content\/uploads\/2019\/11\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg","articleSection":["Sin categorizar"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/","url":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/","name":"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group - Vallis Capital Partners","isPartOf":{"@id":"https:\/\/vallis.pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/#primaryimage"},"image":{"@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/#primaryimage"},"thumbnailUrl":"https:\/\/vallis.pt\/wp-content\/uploads\/2019\/11\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg","datePublished":"2019-11-04T13:36:40+00:00","dateModified":"2024-10-10T15:14:28+00:00","breadcrumb":{"@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/#primaryimage","url":"https:\/\/vallis.pt\/wp-content\/uploads\/2019\/11\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg","contentUrl":"https:\/\/vallis.pt\/wp-content\/uploads\/2019\/11\/Insparya-expande-novas-parcerias-pe7tpiguodj3982tnzidzwwss0ygx1kw6svaivo5r4.jpg","width":1080,"height":720},{"@type":"BreadcrumbList","@id":"https:\/\/vallis.pt\/es\/vsi-ii-lidera-consorcio-com-a-hermes-gpe-que-adquire-50-do-capital-do-grupo-saude-viavel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/vallis.pt\/es\/"},{"@type":"ListItem","position":2,"name":"VSI II lidera un consorcio con Hermes GPE para adquirir el 50% del capital de Viable Health Group"}]},{"@type":"WebSite","@id":"https:\/\/vallis.pt\/#website","url":"https:\/\/vallis.pt\/","name":"VALLIS Capital Partners","description":"","publisher":{"@id":"https:\/\/vallis.pt\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vallis.pt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/vallis.pt\/#organization","name":"VALLIS Capital Partners","alternateName":"Gestora de Fundos Independente, focada exclusivamente em Capital de Risco Private Equity","url":"https:\/\/vallis.pt\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/vallis.pt\/#\/schema\/logo\/image\/","url":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/12\/cropped-favicon-vallis.png","contentUrl":"https:\/\/vallis.pt\/wp-content\/uploads\/2021\/12\/cropped-favicon-vallis.png","width":512,"height":512,"caption":"VALLIS Capital Partners"},"image":{"@id":"https:\/\/vallis.pt\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/valliscapitalpartners\/"]},{"@type":"Person","@id":"https:\/\/vallis.pt\/#\/schema\/person\/f966934c80caeb0ba208e7cadd02a3db","name":"Gest\u00e3o Vallis","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8560397191db0e3e39ba331af05c4bdca9a0da3af8a4d70c5c04547dcce6ca22?s=96&d=mm&r=g","caption":"Gest\u00e3o Vallis"},"url":"https:\/\/vallis.pt\/es\/author\/vallis\/"}]}},"_links":{"self":[{"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/posts\/2153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/comments?post=2153"}],"version-history":[{"count":0,"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/posts\/2153\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/media\/1894"}],"wp:attachment":[{"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/media?parent=2153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/categories?post=2153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vallis.pt\/es\/wp-json\/wp\/v2\/tags?post=2153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}